The cancer characteristic gene set included PTEN, IL21, KRAS, etc. Loss of the tumor-suppressor molecule PTEN is among the most common molecular dysfunctions associated with glioma malignancy (31). This evidence concerns the gene KRAS and central nervous system cancer.